Proposed Intended-Use Amendments Invite Questions About US FDA's Off-Label Intentions
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration issued a proposed rule targeting tobacco products last month that should not be ignored by medical device and drug manufacturers, attorneys say.